Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
BEIJING, Sept 22 (Reuters) - China and Europe should not fight trade wars because the…
WILMINGTON, Delaware, Sept 21 (Reuters) - Private equity firm Silver Lake sued billionaire Carl Icahn…
Sept 21 (Reuters) - Southern Company's unit, Georgia Power, said on Monday it had signed…
Sept 22 (Reuters) - Unico Silver Ltd: * TRADING HALT REQUESTED FOR PROPOSED CAPITAL RAISING…
Good night from the Reuters Daybook. The following items have been added/updated to the Reuters…
By Noel Randewich and Johann M Cherian Sept 21 (Reuters) - The Nasdaq surged to…